Arogundade Fatiu A, Omotoso Bolanle A, Adelakun Adegbola, Bamikefa Titilope, Ezeugonwa Remigus, Omosule Babaniji, Sanusi Abubakr A, Balogun Rasheed A
Clin Nephrol. 2020 Supplement-Jan;93(1):3-7. doi: 10.5414/CNP92S101.
Chronic kidney disease (CKD) particularly in its most severe form, end-stage renal disease (ESRD), is highly prevalent globally. Although both the incidence and prevalence appears to be increasing, the rate of increase is far higher in developing countries, probably as a result of underdevelopment, high incidence of communicable and noncommunicable diseases, poverty as well as inaccessible, unavailable, or unaffordable treatment modalities. The epidemiology differs remarkably between developing and developed economies - it afflicts the young and middle-aged in the former and older individuals in the latter. The etiologies also differ significantly, and the outcome is mainly determined by accessibility and availability of renal replacement therapies. While the three modalities of treatment namely hemodialysis, peritoneal dialysis, and kidney transplantation are available in sub-Saharan Africa, affordability of care remains a major challenge due to nonavailability of healthcare insurance in many of the countries, and where state support is available, dialysis and transplant rationing based on certain criteria remains a major limitation. Data on CKD and ESRD are largely unreliable because of a lack of renal registries in most countries, but the reactivation of the South African Renal Registry and its extension to cover other African countries may improve data quality. .
慢性肾脏病(CKD),尤其是最严重的终末期肾病(ESRD),在全球范围内高度流行。尽管发病率和患病率似乎都在上升,但发展中国家的上升速度要快得多,这可能是由于发展不足、传染病和非传染病的高发病率、贫困以及治疗方式难以获得、无法获得或负担不起所致。发展中经济体和发达经济体的流行病学情况差异显著——在前者中患病的是年轻人和中年人,而在后者中患病的是老年人。病因也有很大不同,结果主要取决于肾脏替代疗法的可及性和可得性。虽然撒哈拉以南非洲地区有血液透析、腹膜透析和肾脏移植这三种治疗方式,但由于许多国家没有医疗保险,医疗保健的可负担性仍然是一个重大挑战,而且在有国家支持的地方,基于某些标准的透析和移植配给仍然是一个主要限制。由于大多数国家缺乏肾脏登记处,CKD和ESRD的数据在很大程度上不可靠,但南非肾脏登记处的重新启动及其扩展以覆盖其他非洲国家可能会提高数据质量。